[1] Somers A, Casteels K, Van Roie E, Spileers W, Casteels I. Non-organic visual loss in children:prospective and retrospective analysis of associated psychosocial problems and stress factors[J]. Acta Ophthalmol, 2016, 94:e312-316.
[2] Mukherjee B, Nayak S. Nonorganic visual loss in a child[J]. Saudi J Ophthalmol, 2021, 34:220-222.
[3] Ozsungur B, Foto-Özdemir D, Ozusta S, Topçu M, Topaloğlu H. Treatment of a severe conversion disorder in a 10-year-old boy:a case study and overview[J]. Turk J Pediatr, 2012, 54:413-418.
[4] Moore Q, Al-Zubidi N, Yalamanchili S, Lee AG. Nonorganic visual loss in children[J]. Int Ophthalmol Clin, 2012, 52:107-123.
[5] van Lint M, Kloeck D, van Aken EH. Lose the nintendo and thou shall be healed:restoring vision in malingering[J]. GMS Ophthalmol Cases, 2022, 12:Doc05.
[6] Raviskanthan S, Wendt S, Ugoh PM, Mortensen PW, Moss HE, Lee AG. Functional vision disorders in adults:a paradigm and nomenclature shift for ophthalmology[J]. Surv Ophthalmol, 2022, 67:8-18.
[7] Daniel MC, Coughtrey A, Heyman I, Dahlmann-Noor AH. Medically unexplained visual loss in children and young people:an observational single site study of incidence and outcomes[J]. Eye (Lond), 2017, 31:1068-1073.
[8] Jamaluddin R, Izham AA, Abdul Hamid AF, Amir Hamzah WN, Abd Hamid MR. Acute bilateral loss of vision as organic manifestation of repressed psychological stress:a case report[J]. Clin Case Rep, 2021, 9:e04809.
[9] Petzold A, Fraser CL, Abegg M, Alroughani R, Alshowaeir D, Alvarenga R, Andris C, Asgari N, Barnett Y, Battistella R, Behbehani R, Berger T, Bikbov MM, Biotti D, Biousse V, Boschi A, Brazdil M, Brezhnev A, Calabresi PA, Cordonnier M, Costello F, Cruz FM, Cunha LP, Daoudi S, Deschamps R, de Seze J, Diem R, Etemadifar M, Flores-Rivera J, Fonseca P, Frederiksen J, Frohman E, Frohman T, Tilikete CF, Fujihara K, Gálvez A, Gouider R, Gracia F, Grigoriadis N, Guajardo JM, Habek M, Hawlina M, Martínez-Lapiscina EH, Hooker J, Hor JY, Howlett W, Huang-Link Y, Idrissova Z, Illes Z, Jancic J, Jindahra P, Karussis D, Kerty E, Kim HJ, Lagrèze W, Leocani L, Levin N, Liskova P, Liu Y, Maiga Y, Marignier R, McGuigan C, Meira D, Merle H, Monteiro MLR, Moodley A, Moura F, Muñoz S, Mustafa S, Nakashima I, Noval S, Oehninger C, Ogun O, Omoti A, Pandit L, Paul F, Rebolleda G, Reddel S, Rejdak K, Rejdak R, Rodriguez-Morales AJ, Rougier MB, Sa MJ, Sanchez-Dalmau B, Saylor D, Shatriah I, Siva A, Stiebel -Kalish H, Szatmary G, Ta L, Tenembaum S, Tran H, Trufanov Y, van Pesch V, Wang AG, Wattjes MP, Willoughby E, Zakaria M, Zvornicanin J, Balcer L, Plant GT. Diagnosis and classification of optic neuritis[J]. Lancet Neurol, 2022, 21:1120-1134.
[10] Peer Mohamed BA, Patil SG. Psychogenic unilateral pseudoptosis[J]. Pediatr Neurol, 2009, 41:364-366.
[11] Yang SL, Zhu J, Lu JH, Wang ZG, Xiao YQ, Dong Q, Han X. Clinical reasoning:a 22-year-old man with progressive bilateral visual loss[J]. Neurology, 2020, 94:625-630.
[12] Smith TJ, Baker RS. Perimetric findings in functional disorders using automated techniques[J]. Ophthalmology, 1987, 94:1562-1566.
[13] Thompson JC, Kosmorsky GS, Ellis BD. Field of dreamers and dreamed-up fields:functional and fake perimetry[J]. Ophthalmology, 1996, 103:117-125.
[14] Frisén L. Identification of functional visual field loss by automated static perimetry[J]. Acta Ophthalmol, 2014, 92:805-809.
[15] Scott JA, Egan RA. Prevalence of organic neuro -ophthalmologic disease in patients with functional visual loss[J]. Am J Ophthalmol, 2003, 135:670-675.
[16] Bennett JL. Optic neuritis[J]. Continuum (MinneapMinn), 2019, 25:1236-1264.
[17] Ayoubi NKE, Moussa H, Younes A, Haddad R, Khoury SJ. Use of retinal optical coherence tomography to differentiate suspected neuromyelitisoptica spectrum disorder from multiple sclerosis:a cross-sectional study[J]. Mult Scler Relat Disord, 2022, 68:104160.
[18] Behbehani R, Ali A, Al-Omairah H, Rousseff RT. Optimization of spectral domain optical coherence tomography and visual evoked potentials to identify unilateral optic neuritis[J]. Mult Scler Relat Disord, 2020, 41:101988.
[19] Zrzavy T, Leutmezer F, Rommer P, Bsteh G, Kornek B, Berger T, Prayer D, Thurnher M, Haider L. Imaging features to distinguish AQP4-positive NMOSD and MS at disease onset:a retrospective analysis in a single-center cohort[J]. Eur J Radiol, 2022, 146:110063.
[20] Chow LS, Paley MNJ. Recent advances on optic nerve magnetic resonance imaging and post-processing[J]. Magn Reson Imaging, 2021, 79:76-84. |